China Pharma Holdings (CPHI) Profit After Tax Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 14.01% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.89% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 15.37% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | China Pharma Holdings | 39.71 Mn | 39.41 Mn | 83,566.00 | -34.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.24% |
| Dec 31, 2025 | 19.24% |
| Sep 30, 2025 | 9.09% |
| Jun 30, 2025 | 15.90% |
| Mar 31, 2025 | 8.62% |
| Dec 31, 2024 | -7.68% |
| Sep 30, 2024 | -5.85% |
| Jun 30, 2024 | -20.36% |
| Mar 31, 2024 | -7.60% |
| Dec 31, 2023 | 6.60% |
| Sep 30, 2023 | -12.96% |
| Jun 30, 2023 | -222.24% |
| Mar 31, 2023 | 10.36% |
| Dec 31, 2022 | 49.83% |
| Sep 30, 2022 | -4.10% |
| Jun 30, 2022 | -1.96% |
| Mar 31, 2022 | -35.08% |
| Dec 31, 2021 | 49.45% |
| Sep 30, 2021 | 37.54% |
| Jun 30, 2021 | 6.47% |